Nevro Shares Now Down 28%; Traders Circulating Doc From US District Judge Showing Conference Scheduled For Aug. 2 To Confirm 'No Live Claims Remain...Judgment Can Be Entered In Full For Boston Scientific'
Benzinga Newsdesk